Back to today’s briefing

Story perspectives

Iambic Therapeutics Hires Michael Secora as CFO

1/7/2025

45 7

Summary

Story summary

Iambic Therapeutics has welcomed Michael Secora as its new Chief Corporate Development Officer and CFO. With over ten years of expertise in technology-driven drug development, Secora is set to elevate Iambic's financial and corporate strategies. His prior success at Recursion, where he forged key partnerships and funding, positions him perfectly to advance Iambic's AI-driven drug discovery and promising clinical pipeline.

1 of 1

Story summary

Iambic Therapeutics has welcomed Michael Secora as its new Chief Corporate Development Officer and CFO. With over ten years of expertise in technology-driven drug development, Secora is set to elevate Iambic's financial and corporate strategies. His prior success at Recursion, where he forged key partnerships and funding, positions him perfectly to advance Iambic's AI-driven drug discovery and promising clinical pipeline.